IBEX 35
10.943,70 -7,80 (-0,07%) Euro Stoxx 50
4.894,02 -8,58 (-0,18%) Dólar/Euro
1,0716 +0,0007 (+0,06%) Petróleo Brent
86,48 +0,09 (+0,10%) Oro
2.336,90 +0,30 (+0,01%) Bitcoin EUR
57.547,67 +704,95 (+1,24%)
NEXGEL, Inc. (NXGLW)
NEXGEL, Inc.
2150 Cabot Boulevard West
Suite B
Langhorne, PA 19047
United States
215 702 8550
https://nexgel.com
Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 19
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Adam R. Levy | CEO, President & Director | 382,2k | N/A | 1963 |
| Mr. Adam E. Drapczuk III | Chief Financial Officer | 208,68k | N/A | 1977 |
| Mr. Gregory Robb | Vice President of Operations | N/A | N/A | N/A |
Descripción
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name. It is also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Gobierno corporativo
El ISS Governance QualityScore de NEXGEL, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
